Literature DB >> 7955409

[14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases.

J Kopitz1, C Gerhard, P Höfler, M Cantz.   

Abstract

Incorporation of the lysosomotropic amine [14C]methylamine by fibroblasts cultured from patients with lysosomal storage diseases and from controls was used to estimate the size of the lysosomal compartment. All cell lines from patients with infantile and juvenile forms of mucopolysaccharidoses, mucolipidoses and oligosacharidoses showed markedly increased radioactivity compared with the normal range of controls. In cells from patients with sphingolipidoses and adult forms of storage diseases, however, methylamine accumulation was not significantly increased. Experimentally induced lysosomal storage by enzyme inhibitors (leupeptin, suramin) also caused increased methylamine accumulation. When the lysosomal pH was determined with fluorescein isothiocyanate-dextran, it was in the range of normal controls (pH 4.7-5.0) in patients cells. Thus, [14C]methylamine accumulation should depend on the volume rather than differences in acidity of the lysosomal compartment and be a measure of its eventual pathological enlargement. We conclude that the determination of [14C]methylamine accumulation in fibroblasts provides a valuable tool in the screening for a variety of lysosomal storage disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955409     DOI: 10.1016/0009-8981(94)90141-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.

Authors:  S M Jansen; J E Groener; W Bax; B J Poorthuis
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

2.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.

Authors:  Ryan S Funk; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

3.  Saturation variant interpretation using CRISPR prime editing.

Authors:  Teija M I Bily; Jason Lequyer; Steven Erwood; Joyce Yan; Nitya Gulati; Reid A Brewer; Liangchi Zhou; Laurence Pelletier; Evgueni A Ivakine; Ronald D Cohn
Journal:  Nat Biotechnol       Date:  2022-02-21       Impact factor: 68.164

4.  Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic.

Authors:  Paul R Pryor; Frank Reimann; Fiona M Gribble; J Paul Luzio
Journal:  Traffic       Date:  2006-10       Impact factor: 6.215

5.  Lysosomal trafficking functions of mucolipin-1 in murine macrophages.

Authors:  Eric G Thompson; Lara Schaheen; Hope Dang; Hanna Fares
Journal:  BMC Cell Biol       Date:  2007-12-21       Impact factor: 4.241

6.  Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis.

Authors:  Mark T Miedel; Youssef Rbaibi; Christopher J Guerriero; Grace Colletti; Kelly M Weixel; Ora A Weisz; Kirill Kiselyov
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.